实验室主要研究工作包括:1.揭示参与Abeta代谢的重要蛋白质如APP、beta-分泌酶和gamma-分泌酶复合体等的生理及病理功能作用; 2.鉴定新的AD相关基因蛋白并阐明其作用机理; 3.确定Abeta和tau造成神经突触功能损害和神经元退行死亡的分子机制。
学习工作经历
承担项目及获奖
承担课题
1. 国家自然科学基金区域联合基金重点项目“CD2AP在不同类型神经细胞中参与Tau疾病的差异作用和机理研究”(U25A2072,2026.01-2029.12),258.5万元,主持。
2. 国家自然科学基金卓越研究群体项目B类“阿尔茨海默病的复杂机制解析和创新诊疗探索”(82588301,2026.01-2030.12),1000万元,骨干。
3. 国家自然科学基金区域联合基金重点项目“基于LTP诱导的表达变化的差异来筛选鉴定参与阿尔茨海默病的新基因”(U21A20361,2022.01-2025.12),260万元,主持。
4. 国家自然科学基金重点项目“RPS23RG1调节抑制性神经突触和参与阿尔茨海默病的功能研究”(82130039,2022.01-2026.12),290万元,主持。
获奖:
2023年度四川省科学技术进步奖一等奖“难治性癫痫耐药机制和精准诊疗策略的研究与应用推广” (排名第2)。
代表性成果
1. Cao J, Meng J, Chen Y, Tang Z, Wang Y, Li K, Zhang X, Luo H, Li H, Wang Z, Zhang YW* (2026) Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection. Alzheimer’s & Dementia. 22:e71202.
2. Zhao S*, Jiang X, Jiang Y, Meng J, Han L, Cao J, Zhu M, Zhou Y, Zhang X, Luo H, Zhang YW*, Li H* (2025) FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway. Neurobiology of Disease, 216: 107145.
3. Zhou Y, Wang Y, Yang H, Zhang C, Meng J, Zhang L, Li K, Huang L, Zhang X, Luo H, Zhang YW* (2025) Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies. Acta Pharmaceutica Sinica B, 15:5817-5831.
4. He J, Zhang L, Xu H, Gao C, Zhao W, Zhang B, Han W, Zhao W, Tan G, Chen S, Zhong P, Shen Z, Meng J, Tang Z, Lu H, Gao X, Li Z, Li W, Mao J, Liu B, Zhang YW*, Wang Z* (2025) CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways. Journal of Experimental & Clinical Cancer Research, 44:228.
5. Zheng N, Wang Z, Cao J, Li K, Xu H, Wang J, Zhang L, Meng J, Tang Z, Luo H, Sun H, Zhang X, Zhang YW* (2025) TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice. Alzheimer’s & Dementia. 21: e70369.
6. Zhao D, Huo Y, Zheng N, Zhu X, Yang D, Zhou Y, Wang S, Jiang Y, Wu Y, Zhang YW* (2025) Mdga2 deficiency leads to an aberrant activation of BDNF/TrkB signaling that underlies autism-relevant synaptic and behavioral changes in mice. Plos Biology. 23:e3003047.
7. Zheng N, Li K, Cao J, Wang Z, Zhang L, Zhao Z, He J, Wang Y, Zhu X, Chen Y, Meng J, Zhao D, Niu M, Luo H, Zhang X, Sun H, Zhang YW* (2025) Electrophysiology-based screening identifies neuronal HtrA serine peptidases 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy. Translational Psychiatry. 15:5.
8. Huo Y, Zhao D, Zhu X, Zheng N, Yang D, Meng J, Chen Y, Zhang YW* (2025) RPS23RG1 inhibits SORT1-mediated lysosomal degradation of MDGA2 to protect against autism. Theranostics, 15:1338-1352.
9. Zhang L, Huang L, Zhou Y, Meng J, Zhang L, Zhou Y, Zheng N, Guo T, Zhao S, Wang Z, Huo Y, Zhao Y, Chen X, Zheng H, Holtzman DM, Zhang YW* (2024) Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis. Molecular Neurodegeneration, 19:95.
10. Hu B, Zhou Y, Wu C, Xiao N, Li J, Li X, Li Y, Zhang X, Huang X, Song Y, Wang Z, Zhang YW*, Zhang Z*, Zheng H*. Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R-Related Disorder (CSF1R-RD) in a Murine Model and CSF1R-RD Patients. Ann Neurol. 2024 Nov 21. doi: 10.1002/ana.27147. Online ahead of print.
11. Han W, Zhang B, Zhao W, Zhao W, He J, Qiu X, Zhang L, Wang X, Wang Y, Lu H, Zhang Y, Xie Y, Geng Y, Zhao W, Huang Q, Zhang YW*, Wang Z* (2025). Ketogenic β-hydroxybutyrate regulates β-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer's mice. Aging Cell. 24: e14368.
12. Zhang L, He J, Zhao W, Zhou Y, Li J, Li S, Zhao W, Zhang L, Tang Z, Tan G, Chen S, Zhang B, Zhang YW*, Wang Z* (2024). CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signaling. Cell Death Dis. 15(10):722. doi: 10.1038/s41419-024-07094-7.
13. Cao J, Zhang YW* (2024). Targeting synaptic pathology in Alzheimer's disease. Zool Res, 45(4):875-876.
14. Meng J, Zhang L, Zhang YW* (2024) Microglial dysfunction in autism spectrum disorder. Neuroscientist, 30: 744-758.
15. Meng J*, Han L, Xu H, Zhang L, Liu Z, Zhou Y, Zhang X, Luo H, Zhang YW* (2024). TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance. Int Immunopharmacol, 127:111445. doi: 10.1016/j.intimp.2023.111445.
16. Zhao S, Jiang X, Han L, Jiang Y, Wang Y, Meng J, Zhu X, Zhang X, Luo H, Zhang YW* (2023) Tau reduction attenuates autism-like features in Fmr1 knockout mice. Molecular Autism, 14:42.
17. Wang T, Zhou Y, Wang Y, Zhang L, Zhu X, Wang X, Wang J, Han L, Meng J, Zhang X, Luo H, Ma Q, Wang Z, Zhang YW* (2023) Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer’s disease. Zoological Research, 44(5):8670881.
18. Jiang Y, Han L, Meng J, Wang Z, Zhou Y, Yuan H, Xu H, Zhao Y, Lu J, Xu H, Zhang C, Zhang YW* (2022) Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits. Mol Ther Methods Clin Dev, 27:246-258.
19. Liu FR, Zhou Y, Wang Y, Huang LL, Zhang X, Luo H, Wu SY, Lyu HY, Huang LH, Xu H, Zhang YW* (2022) Pedigree-based study to identify GOLGB1 as a risk gene for bipolar disorder. Translational Psychiatry, 12:390.
20. Wang C, Zhang Y, Zhao D, Huo Y, Xie J, Zhang X, Luo H, Xu H, Zhang YW* (2022) Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice. Neuropsychopharmacology, 47(12):2042-2050. doi: 10.1038/s41386-022-01373-7.
21. Meng J, Han L, Zheng N, Wang T, Xu H, Jiang Y, Wang Z, Liu Z, Zheng Q, Zhang X, Luo H, Can D, Lu J, Xu H, Zhang YW* (2022) Microglial Tmem59 Deficiency Impairs Phagocytosis of Synapse and Leads to Autism-Like Behaviors in Mice. J Neurosci, 42:4958-4979.
22. Shen Y, Li L, Xiao X, Yang S, Hua Y, Wang Y, Zhang YW*, Zhang Y* (2021) Site-specific photochemical desaturation enables divergent syntheses of Illicium sesquiterpenes. J Am Chem Soc, 143: 3256-3263.
23. Zhao D, Zhou Y, Huo Y, Meng J, Xiao X, Han L, Zhang X, Luo H, Can D, Sun H, Huang TY, Wang X, Zhang J, Liu FR, Xu H, Zhang YW* (2021) RPS23RG1 modulates Tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation. Cell Death Differ. 28(1): 337-348.
学术兼职
Molecular Neurodegeneration杂志,编委。
